Article ; Online: The MHC-E peptide ligands for checkpoint CD94/NKG2A are governed by inflammatory signals, whereas LILRB1/2 receptors are peptide indifferent.
2023 Volume 42, Issue 12, Page(s) 113516
Abstract: The immune checkpoint NKG2A/CD94 is a promising target for cancer immunotherapy, and its ligand major histocompatibility complex E (MHC-E) is frequently upregulated in cancer. NKG2A/CD94-mediated inhibition of lymphocytes depends on the presence of ... ...
Abstract | The immune checkpoint NKG2A/CD94 is a promising target for cancer immunotherapy, and its ligand major histocompatibility complex E (MHC-E) is frequently upregulated in cancer. NKG2A/CD94-mediated inhibition of lymphocytes depends on the presence of specific leader peptides in MHC-E, but when and where they are presented in situ is unknown. We apply a nanobody specific for the Qdm/Qa-1 |
---|---|
MeSH term(s) | Mice ; Animals ; Histocompatibility Antigens Class I/metabolism ; Leukocyte Immunoglobulin-like Receptor B1/metabolism ; Killer Cells, Natural ; Ligands ; Peptides/metabolism ; Neoplasms/metabolism ; NK Cell Lectin-Like Receptor Subfamily C/metabolism |
Chemical Substances | Histocompatibility Antigens Class I ; Leukocyte Immunoglobulin-like Receptor B1 ; Ligands ; Peptides ; NK Cell Lectin-Like Receptor Subfamily C |
Language | English |
Publishing date | 2023-12-03 |
Publishing country | United States |
Document type | Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2649101-1 |
ISSN | 2211-1247 ; 2211-1247 |
ISSN (online) | 2211-1247 |
ISSN | 2211-1247 |
DOI | 10.1016/j.celrep.2023.113516 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.